Occuity’s funding round on crowdfunding platform Seedrs reached its target of £1.8m on the first day of its public launch and is now overfunding.
The funding will be used to accelerate the development of new optical screening and monitoring devices that aim to detect the early signs of chronic health conditions, including diabetes, by scanning the human eye.
Boyes Turner regularly works with some of the world’s most exciting start-ups and largest multinationals. It has an internationally recognised expertise in the technology and innovation sector.
Sophie Payne, Senior Associate from Boyes Turner’s corporate team said: Occuity’s technology has the potential to improve the lives of hundreds of millions of people worldwide. This has been an exciting project to work on and we’re so pleased for the team at Occuity that they reached their funding target so quickly.
Commenting on the support provided by Boyes Turner and their crowdfunding round, Dr. Dan Daly, CEO and Co-founder of Occuity said: The support we have received from Boyes Turner throughout our investment round has been invaluable. Their advice has helped us launch our successful campaign on Seedrs and we’re delighted that our vision of transforming health screening and monitoring has resonated with Seedrs investors.
The team of corporate specialists from Boyes Turner who are advising Occuity include Partner Chris Dobson, Senior Associate Sophie Payne, and Solicitor Rachael Brenchley.
Occuity’s crowdfunding campaign is available on Seedrs at: https://www.seedrs.com/occuity
Occuity’s funding round on crowdfunding platform Seedrs reached its target of £1.8m on the first day of its public launch and is now overfunding.
The funding will be used to accelerate the development of new optical screening and monitoring devices that aim to detect the early signs of chronic health conditions, including diabetes, by scanning the human eye.
Boyes Turner regularly works with some of the world’s most exciting start-ups and largest multinationals. It has an internationally recognised expertise in the technology and innovation sector.
Sophie Payne, Senior Associate from Boyes Turner’s corporate team said: Occuity’s technology has the potential to improve the lives of hundreds of millions of people worldwide. This has been an exciting project to work on and we’re so pleased for the team at Occuity that they reached their funding target so quickly.
Commenting on the support provided by Boyes Turner and their crowdfunding round, Dr. Dan Daly, CEO and Co-founder of Occuity said: The support we have received from Boyes Turner throughout our investment round has been invaluable. Their advice has helped us launch our successful campaign on Seedrs and we’re delighted that our vision of transforming health screening and monitoring has resonated with Seedrs investors.
The team of corporate specialists from Boyes Turner who are advising Occuity include Partner Chris Dobson, Senior Associate Sophie Payne, and Solicitor Rachael Brenchley.
Occuity’s crowdfunding campaign is available on Seedrs at: https://www.seedrs.com/occuity
